Archive for July, 2002

Big Pharma: Getting Too Big for Its Own Good?

Big Pharma: Getting Too Big for Its Own Good? A study by McKinsey & Co. earlier this year looked at the net present value of products out of research vs. the spending on R&D for the top pharma players over the last decade. It found no correlation between the return on investment and a company’s […]


Click here for reuse options!
Copyright 2002 Biotechblog

European Patent Office bars human cloning in patent

European Patent Office bars human cloning in patent The European Patent Office added restrictions on Wednesday to a controversial patent granted in 1999 to prevent it being used to clone humans, a ruling limiting biotech research in Europe.


Click here for reuse options!
Copyright 2002 Biotechblog

Woman carries human clone, group says

Woman carries human clone, group says fringe religious movement’s South Korea-based scientific team yesterday said they had implanted a cloned human embryo in a woman, the latest of a string of similar uncomfirmed experiments to emerge from the underground field of human cloning.


Click here for reuse options!
Copyright 2002 Biotechblog

Monoclonal Antibodies Look to a Bright Future

Monoclonal Antibodies Look to a Bright Future Using mAbs as therapeutics could cut preclinical development time by as much as two-thirds and cost by even greater levels.


Click here for reuse options!
Copyright 2002 Biotechblog

Genomics Sector Has Fired More Than 1,500 Staff Since January 2001

Genomics Sector Has Fired More Than 1,500 Staff Since January 2001 The following is a general compilation of the number of employees at genomic tool and tech firms who have lost their jobs as the industry, bookended by slowdowns at biotech and pharma customers, struggles to stay afloat.


Click here for reuse options!
Copyright 2002 Biotechblog

Biotech Not Cratering, Just Deflating

Biotech Not Cratering, Just Deflating To see where the biotech sector is headed tomorrow, it might be helpful for investors to look back, and more importantly, forget about, the recent past.


Click here for reuse options!
Copyright 2002 Biotechblog

Cuba seeks new drug markets

Cuba seeks new drug markets Inside modern towers that are a pride of Fidel Castro, scientists peer through huge microscopes at tiny proteins they hope to tailor to treat such major killers as AIDS, heart disease and cancer.


Click here for reuse options!
Copyright 2002 Biotechblog

FDA rules need tweaking

FDA rules need tweaking The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.


Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: